Moderna & Vinay Prasad

Moderna: Moderna's mRNA shot for flu was initially refused consideration by the United States — Food and Drug Administration under Vinay Prasad, but the agency reversed its decision after Moderna pledged to challenge it.

Vinay Prasad: Vinay Prasad, Marty Makary's deputy, was pushed out of the United States — Food and Drug Administration twice due to clashes with drugmakers and patient groups, and his controversial vaccine proposals caused internal confusion.

Moderna: Moderna, a manufacturer of widely used COVID-19 vaccines, did not immediately comment on the new policy.

Vinay Prasad: Vinay Prasad, United States — Food and Drug Administration vaccine chief, co-authored the update criticizing the U.S.'s 'one-size-fits-all' approach to COVID boosters.

Vinay Prasad: Dr. Vinay Prasad, the United States — Food and Drug Administration vaccine director, issued the refusal-to-file letter to Moderna, citing issues with its clinical trial methodology.

Vinay Prasad: Dr. Vinay Prasad, director of the United States — Food and Drug Administration's Center for Biologics Evaluation and Research, initially overruled agency reviewers and signed the refusal letter for Moderna's vaccine application, citing concerns about the trial's control arm.

Vinay Prasad: As a top deputy at the United States — Food and Drug Administration, Vinay Prasad co-authored the New England Journal of Medicine piece announcing the change in drug approval requirements. However, he has also taken a more restrictive approach to vaccines and gene therapies, creating some inconsistency.

Vinay Prasad: Vinay Prasad, the United States — Food and Drug Administration's vaccine chief who advocated for placebo-controlled trials, is leaving the agency, which might influence future regulatory approaches.